Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to ...

Novo Nordisk has almost doubled the scale of an R&D alliance with Valo Health – a specialist in applying artificial ...

Valo Health will focus its efforts on using Opal to "discover new therapeutic targets in real-world data, validate those targets in human-centric models, and develop new medicines with [its] AI ...

The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using human data and AI.

At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish ...

Valo Health’s Rho kinase (ROCK ... Novo Nordisk pays $60M for 3 preclinical assets as part of AI-powered cardio collab with Valo “While the data were intrigu­ing, OPL-0401 did not incor ...

The companies originally partnered in September 2023 in an agreement that allowed for the development of up to 11 drug programmes, primarily focused on cardiovascular disease, through which Valo was ...

Novo Nordisk and Valo Health have expanded their agreement to discover and develop new treatments for type 2 diabetes, ...

(Reuters) - Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they ... using human data and artificial intelligence (AI). WHY IT'S IMPORTANT Last month Novo's drug ...

Lexington: Novo Nordisk A/S and Valo Health, Inc. have announced they have entered into an expanded agreement to discover and ...